External broker reports(aggregated public sources), Topline Securities

Topline Securities

External broker reports(aggregated public sources)

Topline Securities is one of the fastest growing brokerage houses in Pakistan. It has strong equity brokerage, economic / equity research, mutual fund distribution, commodity trading and corporate finance & advisory functions. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Air Link Communication / Equity Bottom-Up

Airlink Communication Ltd. is one of the largest manufacturers, distributors, and retailers of smartphones in Pakistan.

<ul><li>Air Link Communication (AIRLINK) announced its 1QFY25 result today, where the company recorded consolidated earnings of Rs842mn (EPS of Rs2.1), up 7% YoY while down 46% QoQ.</li><li>This result came lower than industry expectations due to lower-than-expected sales.</li><li>Net sales clocked in at Rs22bn, down 12% YoY and 40% QoQ. The decline in sales is primarily due to (1) lower inventory levels amid pre buying in June 2024, driven by the imposition of an 18% GST on all mobiles in FY25 budget, and (2) seasonal Muharram days (falling in July 2024), during which sales usually slow down.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Air Link Communication (AIRLINK) announced its 1QFY25 result today, where the company recorded consolidated earnings of Rs842mn (EPS of Rs2.1), up 7% YoY while down 46% QoQ.This result came lower than industry expectations due to lower-than-expected sales.Net sales clocked in at Rs22bn, down 12% YoY and 40% QoQ. The decline in sales is primarily due to (1) lower inventory levels amid pre buying in June 2024, driven by the imposition of an 18% GST on all mobiles in FY25 budget, and (2) seasonal Muharram days (falling in July 2024), during which sales usually slow down.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Air Link Communication (AIRLINK): 1QFY25 EPS at Rs2.1 up 7% YoY - "Buy" stance maintained

Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Sky Quarry Inc. is an oil production, refining, and development-stage environmental remediation company. The Company deploys technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated sands and soils. Sky Quarry serves customers in the United States.

<ul><li>The WTR Sustainable Index was down 2.4% W/W versus the S&amp;P 500 Index (down 1.4%), the Russell 2000 Index (up 0.1%), and the Nasdaq Index (down 1.6%).</li><li>Energy Technology (13.3% of the index) was flat, while Industrial Climate and Ag Technology (47.2% of the index) was down 2.2%, ClimateTech Mining was down 4.4%, and Advanced Transportation Solutions (20.8% of index) was down 2.9%.</li><li>Top 10 Performers: VIHD, MAXN, NXH, SPWR, GCEH, PFIE, EVA, LITM, NXT, AMSC</li></ul>

The WTR Sustainable Index was down 2.4% W/W versus the S&amp;P 500 Index (down 1.4%), the Russell 2000 Index (up 0.1%), and the Nasdaq Index (down 1.6%).Energy Technology (13.3% of the index) was flat, while Industrial Climate and Ag Technology (47.2% of the index) was down 2.2%, ClimateTech Mining was down 4.4%, and Advanced Transportation Solutions (20.8% of index) was down 2.9%.Top 10 Performers: VIHD, MAXN, NXH, SPWR, GCEH, PFIE, EVA, LITM, NXT, AMSC

Sustainable Investing Surveyor Focus on Sky Quarry, Inc. (SKYQ)

Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Grace Therapeutics, Inc. operates as a late-stage biopharma company. The Company focuses on drug delivery and technologies addressing rare and orphan diseases. Grace Therapeutics serves clients in Canada and the United States.

<ul>
<li>Grace is a clinical-stage, biotechnology company focused on rare disease.</li>
<li>Its lead program is for GTX-104, a novel injectable formulation of nimodipine for the treatment of aneurysmal subarachnoid hemorrhage (aSAH).</li>
<li>Other programs include GTX-102 for Ataxia Telangiectasia &amp; GTX-101 for postherpetic neuralgia.</li>
</ul>


Grace is a clinical-stage, biotechnology company focused on rare disease.
Its lead program is for GTX-104, a novel injectable formulation of nimodipine for the treatment of aneurysmal subarachnoid hemorrhage (aSAH).
Other programs include GTX-102 for Ataxia Telangiectasia &amp; GTX-101 for postherpetic neuralgia.


Grace Therapeutics, Inc:  Initiating Coverage – From Confusion to Infusion

External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Northern Ocean Ltd. operates as an international drilling contractor. The Company focuses on distressed asset play on a recovery in the offshore drilling market, as well as owns two semi-submersible rigs, west mira and bollsta dolphin.

Key points<ul><li>NOL is a high-quality rig operator with potential for deepwater drilling</li><li>NOL offers an opportunity for investors interested in exposure to the offshore drilling sector</li><li>NOL presents an asymmetric levered equity play on deepwater drilling for investors willing to take on the associated risks</li></ul>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key pointsNOL is a high-quality rig operator with potential for deepwater drillingNOL offers an opportunity for investors interested in exposure to the offshore drilling sectorNOL presents an asymmetric levered equity play on deepwater drilling for investors willing to take on the associated risksThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Northern Ocean (NOL.OL) - Monday, Aug 5, 2024

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

<ul><li>Citi Pharma (CPHL) announced its 1QFY25 result today, where the company recorded earnings of Rs201mn (EPS of Rs0.88), up 114% YoY and 32% QoQ.</li><li>The result came higher than expectations due to higher than expected net sales.</li><li>CPHL's net sales increased by 19% YoY and 12% QoQ to Rs3.2bn in 1QFY25. This improvement is primarily due to an increase in API volumetric sales and the addition of new formulation products, as per our channel checks.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Citi Pharma (CPHL) announced its 1QFY25 result today, where the company recorded earnings of Rs201mn (EPS of Rs0.88), up 114% YoY and 32% QoQ.The result came higher than expectations due to higher than expected net sales.CPHL's net sales increased by 19% YoY and 12% QoQ to Rs3.2bn in 1QFY25. This improvement is primarily due to an increase in API volumetric sales and the addition of new formulation products, as per our channel checks.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Citi Pharma (CPHL): 1QFY25 EPS at Rs0.88 up 32% QoQ  (Earnings higher than expectations)

Equity Bottom-Up
Equity Bottom-Up Insights

Air Link Communication (AIRLINK): 1QFY25 EPS at Rs2.1 up 7% YoY - "Buy" stance maintained

Air Link Communication (AIRLINK) announced its 1QFY25 result today, where the company recorded consolidated earnings of Rs842mn (EPS of Rs2.1),...

Topline Securities

Sustainable Investing Surveyor Focus on Sky Quarry, Inc. (SKYQ)

The WTR Sustainable Index was down 2.4% W/W versus the S&P 500 Index (down 1.4%), the Russell 2000 Index (up 0.1%), and the Nasdaq Index (down 1.6%).

Water Tower Research

Grace Therapeutics, Inc: Initiating Coverage – From Confusion to Infusion

Grace is a clinical-stage, biotechnology company focused on rare disease.Its lead program is for GTX-104, a novel injectable formulation of...

Zacks Small Cap Research

Northern Ocean (NOL.OL) - Monday, Aug 5, 2024

Potential investment opportunity in NOL for investors interested in exposure to deepwater drilling, with high-quality rigs and the potential for...

Value Investors Club

Citi Pharma (CPHL): 1QFY25 EPS at Rs0.88 up 32% QoQ (Earnings higher than expectations)

Citi Pharma (CPHL) announced its 1QFY25 result today, where the company recorded earnings of Rs201mn (EPS of Rs0.88), up 114% YoY and 32%...

Topline Securities